Search results
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 3 days agoEarlier this month, AbbVie in-licensed exclusive global rights to develop and commercialize...
4 Signs You Should Move Your Savings to Another Bank
Investopedia· 5 days agoGone are the days when almost everyone used one local bank for a standard checking account and an accompanying savings account. When the internet made...
J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
Zacks· 2 days agoJ&J (JNJ) seeks label expansion for Tremfya for treating moderately to severely active Crohn's disease. This marks the second sBLA filing for Tremfya in three months.
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 4 days agoSkyrizi’s approval for the UC indication was based on data from two phase III studies, a 12-week induction study, INSPIRE1 and a 52-week maintenance study, COMMAND2. Skyrizi is already approved ...
How to invest $1 million: 4 strategies
CNN.com· 5 days ago“My family personally lost more than a million dollars when I was a child, leaving us destitute and leading me to pursue a career as a certified...